Targeting fibroblast activation protein (FAP): advances in CAR
Anti
Gene modification strategies for next
CAR
Current Advances in CAR T Cell Therapy for Malignant Mesothelioma
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial
CAR
CAR
FAP
Frontiers
FAP
CAR T
Therapeutic Initiative
Chimeric Antigen Receptor T
